1-(((2R, 3S)-2-(2, 4-difluorophenyl)-3-methyloxiran-2-yl) methyl)-1H-1, 2, 4-triazole CAS 127000-90-2

Pwodwi deskripsyon:

Non pwodwi: 1-(((2R, 3S)-2-(2,4-difluorophenyl)-3-methyloxiran-2-yl) methyl)-1H-1, 2, 4-triazole CAS non: 127000-90-2

 

Synonyms:            

(2R, 3S)-2-(2, 4-Difluorophenyl)-3-méthyle-[(1H-1, 2, 4-triazol-1-yl) méthyle] oxirane; Ravuconazole int-1 1-(((2R, 3S)-2-(2,4-difluorophenyl)-3-methyloxiran-2-yl) methyl)-1H-1, 2, 4-triazole;

1H-1,2,4-Triazole, 1-[[(2R, 3S)-2-(2, 4-difluorophenyl)-3-methyloxiranyl] méthyle]-;

 

Chimik &PhysicalProperties:

Aparans: Solid oswa likid

Asdi: ≥99,0%

Dansite: 1.41±0.1 g/cm3 (predi)

Boiling Point: 371,6±52.0 ° (predi)

Pka: 2.75±0.10 (predi)

Flash Point: 178,5±30.7 ° c

Vapour presyon: 0,0±0,8 mmHg nan 25 ° c

Endeks nan Refraksyon: 1,613

 

Si ou enterese nan pwodwi nou yo oswa gen nenpot kesyon, tanpri santi yo lib yo kontakte nou!

 

Pwodwi anba patant yo ofri pou R &D objektif selman. Sepandan, responsablite final la manti selman ak achte la.

Baj popilè: 1-(((2r,3s)-2-(2,4-difluorophenyl)-3-methyloxiran-2-yl) methyl)-1h-1, 2, 4-triazole cas 127000-90-2, manifaktire, founise, faktori, achte, an aksyon

• On: 4-Methylenepiperidine HydrobroMide CAS 3522-98-3
• Pwochen: 4 - [(2R) -2- (3,4,5,6-tetrahydro-2H-pyran-2-iloksi) -propionil] morfolin CAS 135270-08-5